Barclays PLC Raises Position in Option Care Health, Inc. (NASDAQ:OPCH)

Barclays PLC grew its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 37.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 426,532 shares of the company's stock after purchasing an additional 116,338 shares during the period. Barclays PLC owned about 0.25% of Option Care Health worth $9,895,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of OPCH. Murphy & Mullick Capital Management Corp purchased a new stake in Option Care Health during the fourth quarter worth about $26,000. UMB Bank n.a. increased its stake in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after buying an additional 346 shares during the period. Signaturefd LLC increased its stake in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after buying an additional 1,005 shares during the period. Quadrant Capital Group LLC boosted its holdings in Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after purchasing an additional 1,099 shares in the last quarter. Finally, Sterling Capital Management LLC boosted its holdings in Option Care Health by 638.5% in the fourth quarter. Sterling Capital Management LLC now owns 2,954 shares of the company's stock valued at $69,000 after purchasing an additional 2,554 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a report on Tuesday, April 22nd. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and upped their price target for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. JPMorgan Chase & Co. increased their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Finally, Barrington Research reissued an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a report on Monday, April 21st. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $33.75.

Option Care Health Stock Performance

Shares of NASDAQ OPCH traded up $0.07 during mid-day trading on Monday, hitting $32.97. 2,800,639 shares of the company were exchanged, compared to its average volume of 1,780,958. The stock has a 50 day simple moving average of $33.37 and a 200-day simple moving average of $28.78. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm has a market cap of $5.42 billion, a price-to-earnings ratio of 27.71, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.64% of the stock is owned by insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.